EUVIMEDEUVIMED entdecken
Crossref

73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study

Federica Li Pomi, Mario Vaccaro, Francesco Borgia

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB184

DOI: 10.1016/j.jaad.2026.04.752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Federica Li Pomi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pomi, F. L., Vaccaro, M., & Borgia, F. (2026). 73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study. Journal of the American Academy of Dermatology, 95(1), AB184. https://doi.org/10.1016/j.jaad.2026.04.752

Vancouver

Pomi FL, Vaccaro M, Borgia F. 73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study. Journal of the American Academy of Dermatology. 2026;95(1):AB184. doi:10.1016/j.jaad.2026.04.752

BibTeX
@article{Pomi2026,
  author = {Pomi, Federica Li and Vaccaro, Mario and Borgia, Francesco},
  title = {73301 Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis At 1-Year Follow-Up: A Real-Life Extension Study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB184},
  doi = {10.1016/j.jaad.2026.04.752}
}
Kostenlos starten →